Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/177061
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gianaroli, Luca | - |
dc.contributor.author | Ata, Baris | - |
dc.contributor.author | Lundin, Kersti | - |
dc.contributor.author | Rautakallio-Hokkanen, Satu | - |
dc.contributor.author | Tapanainen, Juha S. | - |
dc.contributor.author | Vermeulen, Nathalie | - |
dc.contributor.author | Veiga, Anna | - |
dc.contributor.author | Mocanu, Edgar | - |
dc.contributor.author | ESHRE COVID-19 Working Group | - |
dc.date.accessioned | 2021-05-06T10:10:33Z | - |
dc.date.available | 2021-05-06T10:10:33Z | - |
dc.date.issued | 2020-11-30 | - |
dc.identifier.uri | http://hdl.handle.net/2445/177061 | - |
dc.description.abstract | The coronavirus disease 2019 (COVID-19) pandemic created a significant impact on medically assisted reproduction (MAR) services. ESHRE decided to mobilize resources in order to collect, analyse, monitor, prepare and disseminate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) knowledge specifically related to ART and early pregnancy. This article presents the impact of the SARS-CoV-2 pandemic focusing on reproductive healthcare. It details the rationale behind the guidance prepared to support MAR services in organizing and managing the re-start of treatments or in case of any future wave of COVID-19 disease. The guidance includes information on patient selection and informed consent, staff and patient triage and testing, adaptation of ART services, treatment planning and code of conduct. The initiatives detailed in this article are not necessarily COVID-specific and such action plans could be applied effectively to manage similar emergency situations in different areas of medicine, in the future. | - |
dc.format.extent | 8 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | Oxford University Press | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1093/humrep/deaa285 | - |
dc.relation.ispartof | Human Reproduction, 2020, vol. 36, num. 2, p. 275-282 | - |
dc.relation.uri | https://doi.org/10.1093/humrep/deaa285 | - |
dc.rights | cc by-nc (c) Gianaroli et al., 2021 | - |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/3.0/es/ | * |
dc.source | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | - |
dc.subject.classification | COVID-19 | - |
dc.subject.classification | SARS-CoV-2 | - |
dc.subject.classification | Reproducció humana assistida | - |
dc.subject.other | COVID-19 | - |
dc.subject.other | SARS-CoV-2 | - |
dc.subject.other | Human reproductive technology | - |
dc.title | The calm after the storm: re-starting ART treatments safely in the wake of the COVID-19 pandemic | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.date.updated | 2021-05-06T07:27:42Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.pmid | 33017461 | - |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
deaa285.pdf | 367.48 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License